Astrazeneca’s revenue surges as pipeline investments pay off Pharma Pascal Soriot, chief executive officer of AstraZeneca, said: "Astrazeneca had a very strong start in 2024 with substantial total revenue growth of 19 per cent in the first quarter.
How much is too much? The CEO pay predicament Pay A growing number of London-listed companies have been asking shareholders to approve radical pay rises for their top execs. Why?